These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18772819)

  • 21. Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.
    Loyet KM; Deforge LE; Katschke KJ; Diehl L; Graham RR; Pao L; Sturgeon L; Lewin-Koh SC; Hollyfield JG; van Lookeren Campagne M
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6628-37. PubMed ID: 22930722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2007 Aug; 16(16):1986-92. PubMed ID: 17576744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration.
    McKay GJ; Silvestri G; Patterson CC; Hogg RE; Chakravarthy U; Hughes AE
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):533-9. PubMed ID: 18806297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population.
    Momozawa Y; Akiyama M; Kamatani Y; Arakawa S; Yasuda M; Yoshida S; Oshima Y; Mori R; Tanaka K; Mori K; Inoue S; Terasaki H; Yasuma T; Honda S; Miki A; Inoue M; Fujisawa K; Takahashi K; Yasukawa T; Yanagi Y; Kadonosono K; Sonoda KH; Ishibashi T; Takahashi A; Kubo M
    Hum Mol Genet; 2016 Nov; 25(22):5027-5034. PubMed ID: 28173125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes.
    Jakobsdottir J; Conley YP; Weeks DE; Ferrell RE; Gorin MB
    PLoS One; 2008 May; 3(5):e2199. PubMed ID: 18493315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The genetic variability of complement system in pathogenesis of age-related macular degeneration].
    Kubicka-Trząska A; Karska-Basta I; Dziedzina S; Sanak M
    Klin Oczna; 2015; 117(2):130-5. PubMed ID: 26638553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific correlation between the major chromosome 10q26 haplotype conferring risk for age-related macular degeneration and the expression of
    Liao SM; Zheng W; Zhu J; Lewis CA; Delgado O; Crowley MA; Buchanan NM; Jaffee BD; Dryja TP
    Mol Vis; 2017; 23():318-333. PubMed ID: 28659708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.
    Leveziel N; Souied EH; Richard F; Barbu V; Zourdani A; Morineau G; Zerbib J; Coscas G; Soubrane G; Benlian P
    Mol Vis; 2007 Nov; 13():2153-9. PubMed ID: 18079691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of age-related macular degeneration along with CFH in Indian patients.
    Kaur I; Katta S; Hussain A; Hussain N; Mathai A; Narayanan R; Hussain A; Reddy RK; Majji AB; Das T; Chakrabarti S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1771-6. PubMed ID: 18436811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration.
    Tsuchihashi T; Mori K; Horie-Inoue K; Gehlbach PL; Kabasawa S; Takita H; Ueyama K; Okazaki Y; Inoue S; Awata T; Katayama S; Yoneya S
    Ophthalmology; 2011 Jan; 118(1):93-100. PubMed ID: 20678803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of single nucleotide polymorphisms in CFH, ARMS2 and HTRA1 genes with risk of age-related macular degeneration in Egyptian patients.
    Abbas RO; Azzazy HM
    Ophthalmic Genet; 2013 Dec; 34(4):209-16. PubMed ID: 23362846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement factor H polymorphism and age-related macular degeneration.
    Edwards AO; Ritter R; Abel KJ; Manning A; Panhuysen C; Farrer LA
    Science; 2005 Apr; 308(5720):421-4. PubMed ID: 15761121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of CFH, HTRA1, ARMS2, VEGF-A and VEGF-R and the appearance of age-related macular degeneration sub-types.
    Cruz-González F; Cabrillo Estévez L; Cañete Campos C; Sánchez-Jara Sánchez A; Juan Marcos L; González-Sarmiento R
    Arch Soc Esp Oftalmol; 2016 Apr; 91(4):177-83. PubMed ID: 26850328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic factors associated with age-related macular degeneration.
    Leveziel N; Tilleul J; Puche N; Zerbib J; Laloum F; Querques G; Souied EH
    Ophthalmologica; 2011; 226(3):87-102. PubMed ID: 21757876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration.
    Kaur I; Katta S; Reddy RK; Narayanan R; Mathai A; Majji AB; Chakrabarti S
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):59-63. PubMed ID: 19696172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTRA1 promoter polymorphism in wet age-related macular degeneration.
    Dewan A; Liu M; Hartman S; Zhang SS; Liu DT; Zhao C; Tam PO; Chan WM; Lam DS; Snyder M; Barnstable C; Pang CP; Hoh J
    Science; 2006 Nov; 314(5801):989-92. PubMed ID: 17053108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population.
    Connolly E; Rhatigan M; O'Halloran AM; Muldrew KA; Chakravarthy U; Cahill M; Kenny RA; Doyle SL
    Br J Ophthalmol; 2018 Dec; 102(12):1691-1695. PubMed ID: 29453225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related macular degeneration: a perspective on genetic studies.
    Patel N; Adewoyin T; Chong NV
    Eye (Lond); 2008 Jun; 22(6):768-76. PubMed ID: 17491602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.